Inventor · disambiguated record
Francois Malouin
Also filed as: MALOUIN FRANCOIS · MALOUIN FRANÇOIS
19 granted patents·8 pending applications·210 citations·filing 1996–2022
94Inventor score
Files withSOCPRA SCIENCES ET GENIE SEC5SOCPRA—SCIENCES ET GENIE S E C5MICROCIDE PHARMACEUTICALS INC4ESSENTIAL THERAPEUTICS INC3ULYSSES PHARMACEUTICAL PRODUCT3
Top patents by PatentIndex Score
27 records- 0186US8889150B2Bacterial vaccine components from Staphylococcus aureus and uses thereofMALOUIN FRANCOIS·Filed 2011·Granted Nov 18, 2014·11 cites·19 claims
- 0284US9566322B2Bacterial vaccine components and uses thereofSOCPRA—SCIENCES ET GÉNIE S E C·Filed 2014·Granted Feb 14, 2017·6 cites·30 claims
- 0383US10029004B2Bacterial vaccine components and uses thereofSOCPRA—SCIENCES ET GENIE S E C·Filed 2016·Granted Jul 24, 2018·3 cites·23 claims
- 0482US6638718B1Methods of screening for compounds active on staphylococcus aureus target genesESSENTIAL THERAPEUTICS INC·Filed 2000·Granted Oct 28, 2003·8 cites·7 claims
- 0582US6630303B1Methods of screening for compounds active on Staphylococcus aureus target genesESSENTIAL THERAPEUTICS INC·Filed 2000·Granted Oct 7, 2003·8 cites·7 claims
- 0681US10576139B2Bacterial vaccine components and uses thereofSOCPRA—SCIENCES ET GENIE S E C·Filed 2018·Granted Mar 3, 2020·2 cites·43 claims
- 0780US6020121AInhibitors of regulatory pathwaysMICROCIDE PHARMACEUTICALS INC·Filed 1996·Granted Feb 1, 2000·67 cites·15 claims
- 0879US6037123AMethods of screening for compounds active on Staphylococcus aureus target genesMICROCIDE PHARMACEUTICALS INC·Filed 1996·Granted Mar 14, 2000·45 cites·60 claims
- 0976US2021393762A1Bacterial vaccine components and uses thereofSOCPRA SCIENCES ET GENIE SEC·Filed 2021·Application pending·0 cites
- 1075US2021322532A1Bacterial vaccine components and uses thereofSOCPRA SCIENCES ET GENIE SEC·Filed 2021·Application pending·0 cites
- 1173US9993491B2Guanine riboswitch binding compounds and their use as antibioticsSOCPRA—SCIENCES ET GENIE S E C·Filed 2015·Granted Jun 12, 2018·3 cites·5 claims
- 1273US6228588B1Methods of screening for compounds active on Staphylococcus aureus target genesMICROCIDE PHARMACEUTICALS INC·Filed 1999·Granted May 8, 2001·30 cites·66 claims
- 1370US11129884B2Bacterial vaccine components and uses thereofSOCPRA—SCIENCES ET GENIE S E C·Filed 2020·Granted Sep 28, 2021·0 cites·20 claims
- 1470US11065322B2Bacterial vaccine components and uses thereofSOCPRA—SCIENCES ET GENIE S E C·Filed 2020·Granted Jul 20, 2021·0 cites·16 claims
- 1567US7410974B2Halogenated Quinazolinyl nitrofurans as antibacterial agentsULYSSES PHARMACEUTICAL PRODUCT·Filed 2004·Granted Aug 12, 2008·5 cites·9 claims
- 1666US11324815B2Vaccine constructs and uses thereof against Staphylococcus infectionsSOCPRA SCIENCES ET GENIE SEC·Filed 2017·Granted May 10, 2022·1 cites·33 claims
- 1765US6187541B1Methods of screening for compounds active on staphylococcus aureus target genesMICROCIDE PHARMACEUTICALS INC·Filed 1999·Granted Feb 13, 2001·18 cites·66 claims
- 1864US9457033B2Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteriaMALOUIN FRANÇOIS·Filed 2012·Granted Oct 4, 2016·3 cites·32 claims
- 1962US10137137B2ATP synthase inhibitors and steroid alkaloids and uses thereof as antimicrobial agents and as potentiators for aminoglycosides against pathogenic bacteriaSOCPRA SCIENCES ET GENIE SEC·Filed 2014·Granted Nov 27, 2018·0 cites·15 claims
- 2060US10716797B2Steroid alkaloids and compositions and kits thereofSOCPRA SCIENCES ET GENIE SEC·Filed 2018·Granted Jul 21, 2020·0 cites·11 claims
- 2157US2022288183A1Vaccine constructs and uses thereof against staphylococcus infectionsSOCPRA SCIENCES ET GENIES S E C·Filed 2022·Application pending·0 cites
- 2251US2007059709A1Staphylococcus aureus antibacterial target genesBENTON BRET·Filed 2003·Application pending·0 cites
- 2347US2012122819A1Guanine riboswitch binding compounds and their use as antibioticsMULHBACHER JEROME·Filed 2010·Application pending·0 cites
- 2445US2008146562A1Halogenated quinazolinyl nitrofurans as antibacterial agentsULYSSES PHARMACEUTICAL PRODUCT·Filed 2007·Application pending·0 cites
- 2539US2008188499A1Carbo- and Hetero-Cyclic Antibiotics and Use ThereofULYSSES PHARMACEUTICAL PRODUCT·Filed 2005·Application pending·0 cites
- 2630US6514746B1Staphylococcus aureus histidine protein kinase essential genesESSENTIAL THERAPEUTICS INC·Filed 1998·Granted Feb 4, 2003·0 cites·6 claims
- 2726US2001006794A1Screening for modulators of biomoleculesFiled 1998·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →